Avatar

About Malvika

This author has not yet filled in any details.
So far Malvika has created 9 blog entries.

COVID 19 Vaccines: Hype or Reason to Hope? Manhattan, NYC | December 23, 2020, 2.00PM Webinar

Covid-19 has caused a dramatic loss of human life worldwide and has devastated countries' economies. Several COVID-19 vaccines under investigation are showing promising results. This Webinar will offer an overview of where we stand regarding vaccine development and will discuss the main challenges faced to ensure vaccines if successful, can help in the fight against [...]

By |2020-11-23T10:29:32+00:00November 23rd, 2020|Upcoming Events|Comments Off on COVID 19 Vaccines: Hype or Reason to Hope? Manhattan, NYC | December 23, 2020, 2.00PM Webinar

This Is Why the COVID-19 Vaccine Is Going to Take Longer Than You Think

If you believe the hype, a COVID-19 vaccine is just weeks away. Experts say widespread vaccination could help bring the deadly pandemic to its knees, so let's hope a safe, effective vaccine emerges from clinical trials. But don't count on getting your shots just yet. Click here to know more.

By |2020-11-19T02:25:17+00:00November 19th, 2020|News-Letters|Comments Off on This Is Why the COVID-19 Vaccine Is Going to Take Longer Than You Think

Bioethicists worry the rich and powerful will get special access to experimental Covid treatments

When President Donald Trump confirmed Oct. 2 that he was diagnosed with Covid-19, he received a cocktail of therapies — some of which hadn’t yet been approved for general use. Click here to read the full article

By |2020-11-12T23:47:17+00:00November 12th, 2020|News-Articles|Comments Off on Bioethicists worry the rich and powerful will get special access to experimental Covid treatments

Make pre-approval Covid-19 vaccines available through expanded access, not an EUA

BioNTech, based in Mainz, Germany, announced positive results Monday about the Covid-19 vaccine it is developing with Pfizer. Click here to read more.

By |2020-11-11T22:11:52+00:00November 11th, 2020|News-Articles|Comments Off on Make pre-approval Covid-19 vaccines available through expanded access, not an EUA

Pfizer-ceo-on-covid-vaccine-efficacy-it-is-a-great-day-for-humanity.html

U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. “It is a great day for science,” Pfizer CEO Albert Bourla told CNBC’s “Squawk Box” Monday morning. [...]

By |2020-11-11T22:08:45+00:00November 11th, 2020|News-Letters|Comments Off on Pfizer-ceo-on-covid-vaccine-efficacy-it-is-a-great-day-for-humanity.html

U.S. Sets New Record; AstraZeneca Vax Delay; Autopsy Study Sheds Light

 As of 8:00 a.m. ET Thursday, the unofficial U.S. tally stood at 9,488,875 cases and 233,734 deaths -- up by 103,369 (another new record) and 1,096, respectively, in the past 24 hours. Click here to read more.

By |2020-11-09T16:05:42+00:00November 9th, 2020|News-Letters|Comments Off on U.S. Sets New Record; AstraZeneca Vax Delay; Autopsy Study Sheds Light

Deliberately injecting volunteers with COVID to test vaccines ‘faster than large-scale trials’: Bioethics professor

New York University bioethics professor Dr. Arthur Caplan says human challenge studies whereby researchers inject volunteers with COVID-19 and then test the efficiency of vaccines, yields faster and more reliable data than large, traditional vaccine testing processes because they are controlling the environment. Click here to watch the video.

By |2020-11-03T16:27:43+00:00November 3rd, 2020|News-Letters|Comments Off on Deliberately injecting volunteers with COVID to test vaccines ‘faster than large-scale trials’: Bioethics professor

Let’s Not Get Too Excited About Having a Vaccine Really Soon

Arthur L. Caplan, PhD Director, Division of Medical Ethics, New York University Langone Medical Center, New York, NY discusses the known COVID-19 vaccine manufacturing and distribution considerations and the unknown timeline for public access. Click here to watch the video.

By |2020-11-03T16:22:53+00:00November 3rd, 2020|News-Letters|Comments Off on Let’s Not Get Too Excited About Having a Vaccine Really Soon

The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug

October was a good month for Gilead Sciences, the giant manufacturer of antivirals headquartered in Foster City, California. On 8 October, the company inked an agreement to supply the European Union with its drug remdesivir as a treatment for COVID-19—a deal potentially worth more than $1 billion. Two weeks later, on 22 October, the U.S. [...]

By |2020-10-30T16:52:07+00:00October 30th, 2020|News-Articles|Comments Off on The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug